HOME > Outline
The first and only partnering event for regenerative medicine in Japan
Since the introduction of new laws and regulations regarding regenerative medicine in November, 2014, Japan now possesses the fastest approval system for regenerative medicines in the world. The country has fast been becoming a hotbed of activity in this emerging field, and it is with these groundbreaking developments in mind that Regenerative Medicine Japan was first held alongside with BioJapan, Asia's premier partnering event for the global biotechnology industry, in 2016.
Pacifico Yokohama in October 2020!This year’s exhibition will be held as originally planned at Pacifico Yokohama.
We will be following the guideline of government's "Gradual Easing Guidelines for Holding Events and Exhibitions".
We will continue to ask participants to your kind cooperation.
In addition, we are considering some online format partnering to increase the opportunity to connect globally.
More details will be announced soon!!
Application deadline is EXTENDED to July 31st and cancellation policy is revisedAs extending the application deadline, we have also revised our cancelation policy.
For more details, please review our Terms and Conditions on the application form.
Thank you very much for your understanding in this matter.
|Early Bird Discount Deadline||March 31, 2020(Tue.)|
|Exhibitor Application Deadline||July 31, 2020(Fri.)|
|Partnering System Open Date||Early August, 2020|
|Pre-event Briefing (in Tokyo)||Mid August, 2020|
|Exhibition||October 14-16, 2020|
|Name||Regenerative Medicine Japan 2020|
|Date & Time||October 14th(Wed.)-16th(Fri.),2020
Exhibition Hall open: 10:00-17:00
Partnering Area open: 08:30–17:00
|Venue||Pacifico Yokohama, Japan (Access)|
|Visitor Entry Fee||5,000 JPY (Admission free when registering in advance online)|
|Partnering Registration Fee||
Exhibitors: 70,000 JPY (incl. tax) per person
Visitors: 90,000 JPY (incl. tax) per person
||Forum for Innovative Regenerative Medicine (FIRM)
Japan Bioindustry Association (JBA)
JTB Communication Design, Inc.